https://adisinsight.springer.com/trials/700360075?error=cookies_not_supported&code=2af1afcf-beb5-450a-9509-269f4b98b740
A Multiregional, Randomized, Double-Blinded, Placebo-Controlled Phase 3 Study of Lerociclib With...
This is a randomized, double-blinded, placebo-controlled Phase 3 clinical trial to compare the combination of lerociclib (administered at 150 mg twice a day